Inside the Journals: Recompensation of Decompensated Cirrhosis in MASLD and MetALD

How do PEth testing and modification of cardiometabolic risk factors impact recompensation of decompensated cirrhosis in MASLD and metALD?  Come discuss with Dr. Reddy, the author of the recent HEPATOLOGY article “Recompensation of decompensated cirrhosis in a spectrum of metabolic dysfunction–related steatotic liver disease, with PEth-corroborated alcohol abstinence and modification of cardiometabolic risk factors.” Read the article here: https://doi.org/10.1097/HEP.0000000000001822